Literature DB >> 3955300

Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.

V C Jordan, R Koch, S Mittal, M R Schneider.   

Abstract

The oestrogenic and antioestrogenic activities of a series of substituted derivatives of 1,1,2 triphenylbut-1-ene have been determined using primary cultures of rat pituitary gland cells to monitor prolactin synthesis in vitro. The relative binding affinity of the agonists for the oestrogen receptor was consistent with their oestrogenic potency. Bis para substitution at C1 of 1,1,2 triphenylbut-1-ene with either phenolic or acetoxy groups produced partial agonists. The antioestrogenic properties were reversible by the incubation of cells with increasing concentrations of oestradiol. The results lend support to a hypothetical single binding site model of oestrogen action, based upon an adaptation of Belleau's macromolecular perturbation theory.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955300      PMCID: PMC1916918          DOI: 10.1111/j.1476-5381.1986.tb10174.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  A MOLECULAR THEORY OF DRUG ACTION BASED ON INDUCED CONFORMATIONAL PERTURBATIONS OF RECEPTORS.

Authors:  B BELLEAU
Journal:  J Med Chem       Date:  1964-11       Impact factor: 7.446

2.  Gonadotrophin inhibiting and anti-fecundity effects of chloramiphene.

Authors:  D E HOLTKAMP; J G GRESLIN; C A ROOT; L J LERNER
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

3.  A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol.

Authors:  L J LERNER; F J HOLTHAUS; C R THOMPSON
Journal:  Endocrinology       Date:  1958-09       Impact factor: 4.736

4.  Culture of enzymatically dispersed pituitary cells: functional validation of a method.

Authors:  W Vale; G Grant; M Amoss; R Blackwell; R Guillemin
Journal:  Endocrinology       Date:  1972-08       Impact factor: 4.736

Review 5.  The pharmacology and clinical uses of tamoxifen.

Authors:  B J Furr; V C Jordan
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

Review 6.  Biochemical pharmacology of antiestrogen action.

Authors:  V C Jordan
Journal:  Pharmacol Rev       Date:  1984-12       Impact factor: 25.468

7.  A new derivative of triphenylethylene: effect on implantation and mode of action in rats.

Authors:  M J Harper; A L Walpole
Journal:  J Reprod Fertil       Date:  1967-02

8.  Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.

Authors:  A C Tate; G L Greene; E R DeSombre; E V Jensen; V C Jordan
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

9.  Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure.

Authors:  V C Jordan; M E Lieberman
Journal:  Mol Pharmacol       Date:  1984-09       Impact factor: 4.436

10.  An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro.

Authors:  M E Lieberman; J Gorski; V C Jordan
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

View more
  17 in total

1.  Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.

Authors:  V Craig Jordan; Ramona Curpan; Philipp Y Maximov
Journal:  J Natl Cancer Inst       Date:  2015-04-02       Impact factor: 13.506

Review 2.  Progress in endocrine approaches to the treatment and prevention of breast cancer.

Authors:  Ifeyinwa Obiorah; V Craig Jordan
Journal:  Maturitas       Date:  2011-10-05       Impact factor: 4.342

Review 3.  The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-10-22       Impact factor: 5.678

Review 4.  The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.

Authors:  Ping Fan; Philipp Y Maximov; Ramona F Curpan; Balkees Abderrahman; V Craig Jordan
Journal:  Mol Cell Endocrinol       Date:  2015-06-05       Impact factor: 4.102

Review 5.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

6.  Differences in the rate of oestrogen-induced apoptosis in breast cancer by oestradiol and the triphenylethylene bisphenol.

Authors:  I E Obiorah; V C Jordan
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

7.  Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells.

Authors:  S Sengupta; I Obiorah; P Y Maximov; R Curpan; V C Jordan
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

8.  Cytotoxic esters of 1,1-bis-(4-hydroxyphenyl)-2-phenyl-but-1-ene with selective antitumor activity against estrogen receptor-containing mammary tumors.

Authors:  M L Schuderer; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

9.  Acetoxy substituted 1,1,2-triphenylbut-1-enes: estrogenic, antiestrogenic and mammary tumor inhibiting activity.

Authors:  M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

10.  The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis.

Authors:  Philipp Y Maximov; Joan S Lewis-Wambi; V Craig Jordan
Journal:  Curr Signal Transduct Ther       Date:  2009-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.